Bilirubin load (syn. bilirubin excretion) is a method that is used to determine the body's ability to release bilirubin into the blood. Bilirubin is a breakdown product of hemoglobin and other red blood cells that are broken down in the liver.
The bilirubin test is carried out as follows: the patient is injected intravenously with a bilirubin solution, which is then released into the blood and excreted from the body in the urine. The level of bilirubin in the blood is measured before and after the solution is given to determine how well the liver is able to excrete bilirubin.
This method is used to diagnose liver diseases such as cirrhosis, hepatitis and others. It may also be useful in assessing the effectiveness of treatment for these diseases.
In addition, a bilirubin test can be used to assess liver function in pregnant women and newborns. This helps determine whether the baby is at risk of developing jaundice.
Overall, the bilirubin test is an important tool in the diagnosis and treatment of liver disease and can be useful to many healthcare professionals.
Bilirubin tests are one of the most informative methods for determining hemolytic disease of the fetus, intrauterine infection of the fetus or maternal toxoplasmosis and Crigler-Nayjar syndrome. The essence of the test is to determine the concentration of bilirubin in the urine of the fetus in response to a test with the subcutaneous administration of three drops of a 5% solution of potassium dichromate to the mother over 2 hours. Prolonged mild hypoxia of the infant increases the lumen of the biliary tract, stimulates bile excretion and increases bilirubin levels during bilirubin load. The concentration of bilirubin after a bilirubin test is compared with the average bilirubin level in